4//SEC Filing
GALECTIN THERAPEUTICS INC 4
Accession 0001179022-16-000131
$GALTCIK 0001133416operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:24 PM ET
Size
5.3 KB
Accession
0001179022-16-000131
Insider Transaction Report
Form 4
Prelack Steven
Director
Transactions
- Award
Stock option (right to buy)
2016-12-15+41,500→ 41,500 totalExercise: $0.89Exp: 2026-12-15→ Common stock (41,500 underlying)
Footnotes (1)
- [F1]The options vest 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001133416
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:24 PM ET
- Size
- 5.3 KB